https://ms.neuro-roche.com.ua/ 2023-12-12T08:52:08+00:00 1.00 https://ms.neuro-roche.com.ua/news 2023-12-12T08:52:08+00:00 0.80 https://ms.neuro-roche.com.ua/protocolsstandarts 2023-12-12T08:52:08+00:00 0.80 https://ms.neuro-roche.com.ua/announcements 2023-12-12T08:52:08+00:00 0.80 https://ms.neuro-roche.com.ua/actionevents 2023-12-12T08:52:08+00:00 0.80 https://ms.neuro-roche.com.ua/page/patient-support-program 2023-12-12T08:52:08+00:00 0.80 https://ms.neuro-roche.com.ua/for-pacients 2023-12-12T08:52:08+00:00 0.80 https://ms.neuro-roche.com.ua/algorithm 2023-12-12T08:52:08+00:00 0.80 https://ms.neuro-roche.com.ua/trials 2023-12-12T08:52:08+00:00 0.80 https://ms.neuro-roche.com.ua/working 2023-12-12T08:52:08+00:00 0.80 https://ms.neuro-roche.com.ua/page/instruction 2023-12-12T08:52:08+00:00 0.80 https://ms.neuro-roche.com.ua/edss-calculator/ 2023-12-12T08:52:08+00:00 0.80 https://ms.neuro-roche.com.ua/news/4153-yak-upovlniti-progresuvannya-rozsyanogo-sklerozu 2023-12-12T08:52:08+00:00 0.80 https://ms.neuro-roche.com.ua/news/4151-sho-oznacha-aktivnst-zahvoryuvannya-pri-rozsyanomu-skleroz 2023-12-12T08:52:08+00:00 0.80 https://ms.neuro-roche.com.ua/news/3959-derzhavnim-ekspertnim-tcentrom-moz-ukrani-zavershena-derzhavna-otcnka-medic 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/news/page/2 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/news/page/3 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/news/page/4 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/news/page/5 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/news/page/6 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/protocolsstandarts/4076-Multiple-sclerosis-in-adults-management 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/protocolsstandarts/4077-Multiple-Sclerosis-Therapy-Consensus-Group-MSTCG-position-statement-on-dise 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/protocolsstandarts/4078-Treatment-Optimization-in-Multiple-Sclerosis-Canadian-MS-Working-Group-Reco 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/protocolsstandarts/4079-Diagnose-und-Therapie-der-Multiplen-Sklerose-NeuromyelitisopticaSpektrumErk 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/protocolsstandarts/4080-ECTRIMSEAN-Guideline-on-the-pharmacological-treatment-of-people-with-multip 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/protocolsstandarts/4081-Practice-guideline-recommendations-summary-Diseasemodifying-therapies-for-a 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/protocolsstandarts/4082-Treatment-Algorithm-for-Multiple-Sclerosis-DiseaseModifying-Therapies 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/protocolsstandarts/4085-UK-consensus-on-pregnancy-in-multiple-sclerosis-Association-of-British-Neur 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/protocolsstandarts/4083-MAGNIMS-consensus-guidelines-on-the-use-of-MRI-in-multiple-sclerosisclinica 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/protocolsstandarts/4084-Consortium-of-MS-Centers-MRI-protocol-and-clinical-guidelines-for-the-diagn 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/announcements/3916-NEUROIMAGING-NOWADAYS-IN-MS 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/actionevents/4118-29-travnya-2023-roku-u-kiv-vdbulasya-vdkrita-panelna-diskusya-prisvyachena- 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/actionevents/4117-vebtranslyatcya-z-EAN-2022-za-uchastyu-gevna-dzhovannon-ta-matildi-ngleze-z 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/actionevents/4116-rozsyanij-skleroz--odna-z-golovnih-prichin-nepratcezdatnost-pri-nevrologchn 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/actionevents/4114-rizik-nfektcjnih-uskladnen-pri-lkuvann-okrelzumabom 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/actionevents/4113-rizik-nfektcjnih-uskladnen-pri-lkuvann-okrelzumabom-dumka-ekspertv 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/actionevents/4112-perehd-na-terapyu-okrelzumabom-pro-sho-neobhdno-pamyatati 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/actionevents/4111-montoring-protyagom-lkuvannya-okrelzumabom 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/actionevents/4110-montoring-protyagom-lkuvannya-okrelzumabom-dumka-ekspertv 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/actionevents/4109-rann-priznachennya--hvorobomodifkuyucho-terap-dumka-ekspertv 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/actionevents/4108-nfektcjn-reaktc-pri-vveden-okrelzumabu 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/actionevents/page/2 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/for-pacients/4156-ECTRIMS-2023-dumka-eksperta 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/for-pacients/4120-yak-rvn-nejroflamentv-legkih-lantcyugv-mozhut-pokrashiti-lkuvannya-patcntv- 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/for-pacients/4090-okrevus-kervnitctvo-z-dozuvannya-ta-zastosuvannya 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/for-pacients/4089-chomu-rann-rozpznavannya-progresuvannya-rozsyanogo-sklerozu-rs-take-vazhliv 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/for-pacients/page/2 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/algorithm/4094-algoritm-poshuku-klnchnogo-viprobuvannya 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/trials/4095-klnchn-viprobuvannya-sho-provodyatsya-v-ukran-nevrologya 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/working/4098-hvorobomodifkuyuchij-preparat-okrevus-okrelzumab-demonstru-visoku-efektivns 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/protocols 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/video 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/page/clinical-trial-search-algorithm 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/page/%D1%81linical-trials-conducted-n-Ukraine-neurology 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/page/what-we-are-working-on 2023-12-12T08:52:08+00:00 0.64 https://ms.neuro-roche.com.ua/edss-calculator/documents/description_functions_01.pdf 2023-08-23T14:52:51+00:00 0.64 https://ms.neuro-roche.com.ua/edss-calculator/documents/description_functions_02.pdf 2023-08-23T14:52:51+00:00 0.64 https://ms.neuro-roche.com.ua/edss-calculator/documents/description_functions_03.pdf 2023-08-23T14:52:50+00:00 0.64 https://ms.neuro-roche.com.ua/edss-calculator/documents/description_functions_04.pdf 2023-08-23T14:52:52+00:00 0.64 https://ms.neuro-roche.com.ua/edss-calculator/documents/description_functions_05.pdf 2023-08-23T14:52:51+00:00 0.64 https://ms.neuro-roche.com.ua/edss-calculator/documents/description_functions_06.pdf 2023-08-23T14:52:52+00:00 0.64 https://ms.neuro-roche.com.ua/edss-calculator/documents/description_functions_07.pdf 2023-08-23T14:52:52+00:00 0.64 https://ms.neuro-roche.com.ua/edss-calculator/documents/description_functions_08.pdf 2023-08-23T14:52:50+00:00 0.64 https://ms.neuro-roche.com.ua/multimedia/pdf/2023/news/vysnovok-z-derzhavnoyi-omt-okrelizumab-vid-05-07-2023.pdf 2023-08-23T15:40:24+00:00 0.51 https://ms.neuro-roche.com.ua/news/3944-ECTRIMS-2022klnchn-ta-ekonomchn-rezultati-z-realno-praktiki-u-patcntvz-rozs 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/news/3939-osnovn-tezi-kongresu-ECTRIMS-2022 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/news/3936-osnovn-polozhennya-ECTRIMS-2022-u-yakij-sposb-mozhna-viyaviti-rann-progresu 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/news/3925-rannj-pochatok-terap-preparatom-okrevus-okrelzumab-stvorenim-naukovtcyami-k 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/news/3923-osnovn-polozhennya-kongresu-vropejsko-akadem-nevrolog-shodo-okrelzumabu-202 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/news/3922-osnovn-polozhennya-kongresu-amerikansko-akadem-nevrolog-z-pitan-nejromunolo 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/news/4130-NEUROIMAGING-NOWADAYS-IN-MS 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/news/4133-hvorobomodifkuyuchij-preparat-okrevus-okrelzumab-demonstru-visoku-efektivns 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/news/4132-klnchn-viprobuvannya-sho-provodyatsya-v-ukran-nevrologya 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/news/3886-rozsyanij-skleroz-marshrut-patcnta 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/news/3855-nfektcjn-uskladnennya-terap-rozsyanogo-sklerozu 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/news/3854-lkuvannya-rozsyanogo-sklerozu-v-umovah-pandem-COVID19 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/news/3853-rozsyanij-skleroz-chas-zmniti-nash-fokus 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/news/3851-presrelz-u-schn-2018-roku-okrelzumab-buv-shvalenij-v-vropejskomu-soyuz-dlya 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/news/3828-presrelz-kongres-ECTRIMS 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/news/3825-presrelz-u-berezn-2017-roku-FDA-shvalilo-okrelzumab-dlya-lkuvannya-retcidiv 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/actionevents/4107-nfuzjn-reaktc-pri-vvedenn-okrelzumabu-dumka-ekspertv 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/actionevents/4106-nejroflamenti-legkih-lantcyugv-yak-bomarker-efektivnost-terap-rozsyanogo-sk 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/actionevents/4115-obgruntuvannya-rannogo-priznachennya-visokoefektivno-hvorobomodifkuyucho-te 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/actionevents/4105-efektivnst-okrelzumabu-pri-pervinnoprogresuyuchomu-rozsyanomu-skleroz-dosld 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/actionevents/4104-efektivnst-okrelzumabu-pri-pervinnoprogresuyuchomu-rozsyanomu-skleroz-dosld 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/actionevents/4103-efektivnst-okrelzumabu-pri-pervinnoprogresuyuchomu-rozsyanomu-skleroz-dosld 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/actionevents/4101-efektivnst-okrelzumabu-pri-pervinnoprogresuyuchomu-rozsyanomu-skleroz-dosld 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/for-pacients/3934-yak-upovlniti-progresuvannya-rozsyanogo-sklerozu 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/for-pacients/3933-znachne-pdvishennya-vizhivanost-patcntv-yak-dotrimuyutsya-rezhimu-prijomu-p 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/for-pacients/3932-sho-take-rozsyanij-skleroz 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/for-pacients/3829-zhivi-svom-zhittyam-vsuperech-rozsyanomu-sklerozu 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/for-pacients/3826-nternetresursi-dlya-patcntv-z-rozsyanim-sklerozom 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/multimedia/pdf/2023/protocols/multiple-sclerosis-in-adults-en.pdf 2023-08-23T15:40:24+00:00 0.51 https://ms.neuro-roche.com.ua/multimedia/pdf/2023/protocols/multiple-sclerosis-in-adults-ua.pdf 2023-08-23T15:40:33+00:00 0.51 https://ms.neuro-roche.com.ua/multimedia/pdf/2023/protocols/mstcg-en.pdf 2023-08-23T15:40:34+00:00 0.51 https://ms.neuro-roche.com.ua/multimedia/pdf/2023/protocols/mstcg-ua.pdf 2023-08-23T15:40:34+00:00 0.51 https://ms.neuro-roche.com.ua/multimedia/pdf/2023/protocols/canadian-ms-working-group-en.pdf 2023-08-23T15:40:33+00:00 0.51 https://ms.neuro-roche.com.ua/multimedia/pdf/2023/protocols/canadian-ms-working-group-ua.pdf 2023-08-23T15:40:32+00:00 0.51 https://ms.neuro-roche.com.ua/multimedia/pdf/2023/protocols/diagnose-therapie-multiple-sklerose-ger.pdf 2023-08-23T15:40:31+00:00 0.51 https://ms.neuro-roche.com.ua/multimedia/pdf/2023/protocols/diagnose-therapie-multiple-sklerose-ua.pdf 2023-08-23T15:40:41+00:00 0.51 https://ms.neuro-roche.com.ua/video/3919-vebtranslyatcya-z-EAN-2022-za-uchastyu-gevna-dzhovannon-ta-matildi-ngleze-z 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/video/3876-rozsyanij-skleroz--odna-z-golovnih-prichin-nepratcezdatnost-pri-nevrologchn 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/video/3849-rizik-nfektcjnih-uskladnen-pri-lkuvann-okrelzumabom 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/video/3848-rizik-nfektcjnih-uskladnen-pri-lkuvann-okrelzumabom-dumka-ekspertv 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/video/3847-perehd-na-terapyu-okrelzumabom-pro-sho-neobhdno-pamyatati 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/video/3846-montoring-protyagom-lkuvannya-okrelzumabom 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/video/3845-montoring-protyagom-lkuvannya-okrelzumabom-dumka-ekspertv 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/video/3844-rann-priznachennya--hvorobomodifkuyucho-terap-dumka-ekspertv 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/video/3843-nfektcjn-reaktc-pri-vveden-okrelzumabu 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/video/page/2 2023-12-12T08:52:08+00:00 0.51 https://ms.neuro-roche.com.ua/video/3842-nfuzjn-reaktc-pri-vvedenn-okrelzumabu-dumka-ekspertv 2023-12-12T08:52:08+00:00 0.41 https://ms.neuro-roche.com.ua/video/3841-nejroflamenti-legkih-lantcyugv-yak-bomarker-efektivnost-terap-rozsyanogo-sk 2023-12-12T08:52:08+00:00 0.41 https://ms.neuro-roche.com.ua/video/3840-obgruntuvannya-rannogo-priznachennya-visokoefektivno-hvorobomodifkuyucho-te 2023-12-12T08:52:08+00:00 0.41 https://ms.neuro-roche.com.ua/video/3839-efektivnst-okrelzumabu-pri-pervinnoprogresuyuchomu-rozsyanomu-skleroz-dosld 2023-12-12T08:52:08+00:00 0.41 https://ms.neuro-roche.com.ua/video/3838-efektivnst-okrelzumabu-pri-pervinnoprogresuyuchomu-rozsyanomu-skleroz-dosld 2023-12-12T08:52:08+00:00 0.41 https://ms.neuro-roche.com.ua/video/3837-efektivnst-okrelzumabu-pri-pervinnoprogresuyuchomu-rozsyanomu-skleroz-dosld 2023-12-12T08:52:08+00:00 0.41 https://ms.neuro-roche.com.ua/video/3824-efektivnst-okrelzumabu-pri-pervinnoprogresuyuchomu-rozsyanomu-skleroz--dosl 2023-12-12T08:52:08+00:00 0.41